Compare SBFM & TWAV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SBFM | TWAV |
|---|---|---|
| Founded | 2006 | N/A |
| Country | United States | United States |
| Employees | N/A | 130 |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Programming Data Processing |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.3M | 4.9M |
| IPO Year | 2008 | 2000 |
| Metric | SBFM | TWAV |
|---|---|---|
| Price | $1.15 | $1.29 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $7.00 | N/A |
| AVG Volume (30 Days) | ★ 393.8K | 25.0K |
| Earning Date | 04-03-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 90.77 |
| EPS | N/A | ★ 0.43 |
| Revenue | ★ $36,305,891.00 | $2,437,000.00 |
| Revenue This Year | $40.47 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $3.13 |
| Revenue Growth | ★ 4.11 | 2.48 |
| 52 Week Low | $0.25 | $0.58 |
| 52 Week High | $3.05 | $2.58 |
| Indicator | SBFM | TWAV |
|---|---|---|
| Relative Strength Index (RSI) | 40.08 | 43.47 |
| Support Level | $1.09 | $1.26 |
| Resistance Level | $1.29 | $1.49 |
| Average True Range (ATR) | 0.09 | 0.09 |
| MACD | 0.02 | -0.01 |
| Stochastic Oscillator | 40.07 | 13.04 |
Sunshine Biopharma Inc is a pharmaceutical company offering and researching life-saving medicines in a wide variety of therapeutic areas, including oncology and antivirals. Through its subsidiaries, the company has various generic prescription drugs on the market in Canada and is also involved in developing and selling OTC supplements. In addition, the company is conducting a proprietary drug development program, which is comprised of K1.1 mRNA targeted for liver cancer and SBFM-PL4, PLpro protease inhibitor for SARS Coronavirus infections.
TaoWeave Inc is a digital asset company. The company offers investors a regulated, publicly traded vehicle to gain exposure to the decentralized AI economy. The company aims to invest in the Bittensor ecosystem through partnerships with subnets, miners, and validators, and operates with zero debt by maintain appropriate cash reserves. The Company currently operates in three segments: (1) "Digital Assets", which represents the business surrounding treasury activity with Bittensor, (2) Collaboration Products which represents the business surrounding Mezzanine product offerings, and (3) Managed Services, which represents the business surrounding managed services for video collaboration and network solutions.